Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Sage Therapeutics' Zulresso becomes first treatment for post-partum depression approved in US

firstwordpharmaMarch 20, 2019

Tag: FDA , SAGE Therapeutics , Zulresso

PharmaSources Customer Service